BRIEF-Biotec Pharmacon says Woulgan will be listed on UK Drug Tariff

* Says its wholly owned subsidiary Biotec BetaGlucans received feedback from NHS that Woulgan, a wound treatment product, will be listed on UK Drug Tariff from January 2018 [Source]

Origin: reuters.com

Category: companyNews

Topics: Tariff, listed, Woulgan, January, treatment product, wound, feedback, BetaGlucans received, Biotec, subsidiary, owned, wholly, Pharmacon, BRIEF-Biotec

Source: http://feeds.reuters.com/~r/reuters/companyNews/~3/um9ft-3iznI/brief-biotec-pharmacon-says-woulgan-will-be-listed-on-uk-drug-tariff-idUSFWN1MU10Y